These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29278982)

  • 1. The Use of Kcentra
    Pereira D; Liotta E; Mahmoud AA
    J Pharm Pract; 2018 Feb; 31(1):120-125. PubMed ID: 29278982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new kid on the block: Outcomes with Kcentra 1 year after approval.
    Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R
    J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-Factor Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients With Liver Disease.
    Huang WT; Cang WC; Derry KL; Lane JR; von Drygalski A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):1028-1035. PubMed ID: 27628534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
    Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
    J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of 3- and 4-Factor Prothrombin Complex Concentrate in Patients With Elevated INR.
    Mohan S; Howland MA; Lugassy D; Jacobson J; Su MK
    J Pharm Pract; 2018 Jun; 31(3):262-267. PubMed ID: 28468525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study.
    Dodhiawala PB; Pribyl K; Larson J; Vakayil V; Chandrashekar M; Lord A; Welbig J; Zantek ND; Martin D; Harmon JV
    Clin Appl Thromb Hemost; 2023; 29():10760296231198038. PubMed ID: 37649304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
    Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
    Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin complex concentrate (Octaplex): a Portuguese experience in 1152 patients.
    Carvalho MC; Rodrigues AG; Conceição LM; Galvão ML; Ribeiro LC
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):222-8. PubMed ID: 22450543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin Complex Concentrate Reversal of Coagulopathy in Emergency General Surgery Patients.
    Younis M; Ray-Zack M; Haddad NN; Choudhry A; Hernandez MC; Wise K; Zielinski MD
    World J Surg; 2018 Aug; 42(8):2383-2391. PubMed ID: 29392436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
    Kuroski JE; Young S
    Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
    Franklin SW; Szlam F; Fernandez JD; Leong T; Tanaka KA; Guzzetta NA
    Anesth Analg; 2016 Apr; 122(4):935-42. PubMed ID: 26599794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of Prothrombinex use by SAAS MedSTAR.
    Fischer R; Brettig S; Pearce A
    Emerg Med Australas; 2017 Apr; 29(2):178-183. PubMed ID: 27875857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.
    Ghadimi K; Levy JH; Welsby IJ
    Anesth Analg; 2016 May; 122(5):1287-300. PubMed ID: 26983050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of four-factor prothrombin complex concentrate in the reversal of warfarin-induced and nonvitamin K antagonist-related coagulopathy.
    Young H; Holzmacher JL; Amdur R; Gondek S; Sarani B; Schroeder ME
    Blood Coagul Fibrinolysis; 2017 Oct; 28(7):564-569. PubMed ID: 28604569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.